Skip Navigation



Europace Advance Access published online on November 19, 2007

Europace, doi:10.1093/europace/eum245
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/1/59    most recent
eum245v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stöllberger, C.
Right arrow Articles by Finsterer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stöllberger, C.
Right arrow Articles by Finsterer, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

Cardiac resynchronization therapy in left ventricular hypertrabeculation/non-compaction and myopathy

Claudia Stöllberger1,*, Gerhard Blazek2, Elisabeth Bucher1 and Josef Finsterer3

1 2. Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Juchgasse 25, 1030 Wien, Österreich; 2 Medizinische Abteilung, Hanusch Krankenhaus, Heinrich-Collin-Straße 30, 1140 Wien, Österreich; 3 Krankenanstalt Rudolfstiftung, Juchgasse 25, 1030 Wien, Österreich

Aims: Little is known how patients with left ventricular hypertrabeculation/non-compaction (LVHT) and heart failure respond to cardiac resynchronization therapy (CRT).

Methods and results: Included in this retrospective study were 8/102 patients (3 female, age range 43–78 years), in whom LVHT was diagnosed and in whom a CRT system was implanted. All eight patients were investigated neurologically and in seven of them a myopathy was found. The mean follow-up after CRT implantation was 39 (4–68) months. All patients improved by one or more New York Heart Association (NYHA) classes, and two by two NYHA classes. The left ventricular end-diastolic diameter decreased by ≤5% in 2 patients, by 6–10% in 3 patients, by 12% in 1 patient, and by >30% in 2 patients. The left ventricular systolic function, as assessed by the fractional shortening, did not change in 2 patients, increased by 10% in 2 patients, by 59% in 1 patient, doubled in 2 patients, and showed a five-fold increase in 1 patient. Two patients died during follow-up.

Conclusion: CRT by biventricular pacing in LVHT, heart failure, and myopathy leads to improvement in functional capacity in all patients and improvement of systolic function in half of the patients. The weak response of LVHT patients to CRT may be due to inappropriate selection or comorbidities, in particular, neuromuscular disorders.

Key Words: Cardiomyopathy, Heart failure, Myopathy, Cardiac resynchronization therapy, Biventricular pacemaker


* Corresponding author: Steingasse 31/18, A-1030 Wien, Österreich. Tel/fax: +43 1 713 98 70. E-mail address: claudia.stoellberger{at}chello.at

Manuscript submitted 25 July 2007. Accepted after revision 15 October 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
A. Avella, G. d'Amati, and C. Tondo
Diagnosis of arrhythmogenic right ventricular cardiomyopathy: the role of endomyocardial biopsy guided by electroanatomic voltage map
Europace, July 1, 2009; 11(7): 970 - 970.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.